Yazici Mustafa, Demircan Sabri, Durna Kenan, Sahin Mahmut
Ondokuz Mayis University, Medical School, Department of Cardiology, Samsun, Turkey.
Angiology. 2007 Aug-Sep;58(4):393-400. doi: 10.1177/0003319707305118. Epub 2007 Jul 24.
The aim of this study was to investigate the role of adrenergic activity in patients with slow coronary flow (SCF) and its relationship to TIMI frame count on the pathogenesis of SCF. Plasma noradrenalin and adrenalin concentrations at rest were compared in 51 patients diagnosed with SCF through coronary angiography and TIMI frame count; and 44 healthy controls with normal coronary flow (NCF). Furthermore, the relationship between TIMI frame count and noradrenalin and adrenalin levels was investigated. Plasma noradrenalin (127.9 +/-9.2 and 79.3 +/- 7.3 ng/mL, p < 0.0001) and adrenalin levels (63.9 +/- 2.6 and 44.7 +/- 2.8 ng/mL, p < 0.0001) were higher in patients with SCF when compared to patients with NCF. Noradrenalin and adrenalin levels were effected with SCF-dominant vessels with respect to TIMI frame count (p = 0.012 and p < 0.0001). Patients with SCF in 1, 2, or 3 vessels had different noradrenalin and adrenalin levels (p <0.003 and p < 0.0001). Patients with TIMI frame count above the 75th percentile had significantly higher noradrenalin and adrenalin levels when compared with those between the 25th-50th percentiles and below (p < 0.001 and p = 0.011, respectively). Correlation analysis established that both adrenalin and noradrenalin levels were correlated with TIMI frame counts of left anterior descending (LAD) and circumflex (Cx) arteries. Exercise testing revealed ischemia in 6 patients. Their TIMI frame counts were above the 75th percentile, and they had higher noradrenalin and adrenalin levels when compared with those without ischemia (p = 0.029, p = 0.045). Higher noradrenalin and adrenalin levels and correlation between TIMI frame count and ischemia in patients with SCF suggest that increased adrenergic activity may be the manifestation of slow coronary flow.
本研究旨在探讨肾上腺素能活性在冠状动脉血流缓慢(SCF)患者中的作用及其与心肌梗死溶栓治疗(TIMI)帧数在SCF发病机制中的关系。通过冠状动脉造影和TIMI帧数比较了51例经诊断为SCF的患者静息时血浆去甲肾上腺素和肾上腺素浓度;以及44例冠状动脉血流正常(NCF)的健康对照者。此外,还研究了TIMI帧数与去甲肾上腺素和肾上腺素水平之间的关系。与NCF患者相比,SCF患者的血浆去甲肾上腺素(127.9±9.2和79.3±7.3 ng/mL,p<0.0001)和肾上腺素水平(63.9±2.6和44.7±2.8 ng/mL,p<0.0001)更高。就TIMI帧数而言,去甲肾上腺素和肾上腺素水平受SCF优势血管的影响(p = 0.012和p<0.0001)。单支、双支或三支血管存在SCF的患者去甲肾上腺素和肾上腺素水平不同(p<0.003和p<0.0001)。TIMI帧数高于第75百分位数的患者与第25 - 50百分位数及以下的患者相比,去甲肾上腺素和肾上腺素水平显著更高(分别为p<0.001和p = 0.011)。相关性分析表明,肾上腺素和去甲肾上腺素水平均与左前降支(LAD)和回旋支(Cx)动脉的TIMI帧数相关。运动试验显示6例患者存在缺血。他们的TIMI帧数高于第75百分位数,与无缺血患者相比,去甲肾上腺素和肾上腺素水平更高(p = 0.029,p = 0.045)。SCF患者中较高的去甲肾上腺素和肾上腺素水平以及TIMI帧数与缺血之间的相关性表明,肾上腺素能活性增加可能是冠状动脉血流缓慢的表现。